icon-folder.gif   Conference Reports for NATAP  
 
  International Symposium on Viral Hepatitis and Liver Disease
March 20th - 24th 2009
Washington, DC
Back grey_arrow_rt.gif
 
 
 
Two Year Tenofovir Disoproxil Fumarate (TDF) Treatment and Adefovir Dipivoxil (ADV) Switch Data in HBeAg-Positive Patients With Chronic Hepatitis B (Study 103)
 
 
  Reported by Jules Levin
13th International Symposium on Viral Hepatitis and Liver Disease
March 20th-24th 2009
Washington DC
 
E Jenny Heathcote1, Ed Gane2, Robert deMan3, Sing Chan4, William Sievert5, Stefan Mauss6, Patrick Marcellin7, Jeff Sorbel8, Jane Anderson8, Elsa Mondou8, Joe Quinn8, and Franck Rousseau8 1Toronto Western Hospital, University of Toronto, Toronto Ontario, Canada; 2Middlemore Hospital, Auckland, New Zealand; 3Erasmus MC, University Medical Center Rotterdam, The Netherlands; 4Dreamwork Medical Group, Flushing NY; 5Monash University, Melbourne, VIC, Australia; 6Center for HIV and Gastroenterology, Dusseldorf, Germany; 7Hopital Beaujon, Clichy France; 8Gilead Sciences, Durham NC

lossTdf-1.gif

amm.gif

Week-3.gif

HBVDNBA-4.gif

were-5.gif

on-6.gif

switch-7.gif

atl-8.gif

loss-9.gif

seroWeek-10.gif

Had-11.gif

TDF-12.gif

G3-13.gif